KRYS Stock: Price, Earnings History and SEC Filings
Krystal Biotech, Inc. (KRYS) last traded at $332.29, up 2.38% on the latest session and down 0.1% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $1.79 against an analyst estimate of $1.70, a beat of 5.3%.
$332.29 +2.38%
1 month-0.08%
52-week high$382.54
52-week low$184.02
Volume330,314
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
KRYS earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 3, 2026 | $1.79 | $1.70 | +5.29% |
| Mar 2026 | May 4, 2026 | $1.83 | $1.45 | +26.21% |
| Dec 2025 | Feb 17, 2026 | $1.70 | $1.62 | +4.94% |
| Sep 2025 | Nov 3, 2025 | $2.66 | $1.12 | +137.50% |
KRYS beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for KRYS
SEC filing data is not available right now. You can search for KRYS on SEC EDGAR.
KRYS news
- Has The Story Under Krystal Biotech Stock Run Out?Oct 28, 2026 · trefis.com
- Amgen (AMGN) Reports Next Week: Wall Street Expects Earnings GrowthOct 27, 2026 · finance.yahoo.com
- Analysts Estimate Krystal Biotech, Inc. (KRYS) to Report a Decline in Earnings: What to Look Out forOct 26, 2026 · finance.yahoo.com
- Krystal Biotech to Report Third Quarter 2026 Financial Results on November 2, 2026Oct 22, 2026 · finance.yahoo.com
- Cystic Fibrosis Market Poised for Growth During the Forecast Period (2026-2036) as CFTR Modulators Transform Treatment Landscape | DelveInsightOct 21, 2026 · finance.yahoo.com
About Krystal Biotech, Inc.
Krystal Biotech, Inc. (KRYS) is a US-listed public company on Nasdaq.